← Eichor
Condition: Hepatocholangiocarcinoma Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Hepatocholangiocarcinoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A French Multicenter Observational Retrospective Study of Rare Primary Liver Cancers
Phase N/A · 40 location(s) · Federation Francophone de Cancerologie Digestive · NCT06541652Novel Subtypes and Treatment Strategies of Patients with Unresectable Combined Hepatocellular Cholangiocarcinoma Based o
Phase N/A · 1 location(s) · Zhongda Hospital · NCT06849180HAIC Combined With Camrelizumab Plus Rivoceranib for Advanced Mixed Hepatocellular-cholangiocarcinoma (HCC-CCA)
Phase 2 · 1 location(s) · Fudan University · NCT07105748
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.